In an era where precision medicine and individualized healthcare are revolutionizing clinical practice, comprehending genetic variations has become increasingly important for enhancing human health. This authoritative volume examines the advances in methods for unraveling the causalities of genetic variations and cytogenetics, providing readers with a detailed analysis of powerful analytical methods that assess causal relationships, and how changes in DNA sequence, ranging from single-nucleotide polymorphisms to intricate chromosomal rearrangements, affect susceptibility to disease, responses to therapy, and population health outcomes. The book conjoins fundamental genetic concepts with methodological breakthroughs, including Mendelian randomization, next-generation sequencing, polygenic risk scoring, and high-performance computational genomics. The reader will discover how new approaches are revolutionizing the diagnosis of microdeletion syndrome, enabling accurate genotype-phenotype correlations that guide clinical decision-making. The book integrates concepts from population genetics and evolutionary biology in a unique way to explain how natural selection and migration gradients have shaped current genetic diversity and disease resistance mechanisms. Special emphasis is placed on emerging methodologies, such as Environmental Pollutant-based Polygenic Risk Scores and Mendelian randomization approaches, that develop novel paradigms in gene-environment interactions. From antibiotic resistance mechanisms to cancer susceptibility risk factors, the book provides insightful critical examinations of how genetic research is addressing contemporary public health challenges. The convergence of artificial intelligence and machine learning technologies is a sign of the future direction of gene research and the identification of therapeutic targets. This book is essential for researchers, clinicians, and graduate students who want to understand the complex relationship between genetic variation and human disease. It highlights ethical considerations and the appropriate use of genetic medicine within diverse, global populations.